Carolyn A. Joswig-Jones

发表

Why Do Most Human Liver Cytosol Preparations Lack Xanthine Oxidase Activity?

Jeffrey P. Jones, Erin G. Schuetz, Timothy Wong, 2014, Drug Metabolism and Disposition.

Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.

Jeffrey P. Jones, Upendra P. Dahal, Carolyn A. Joswig-Jones, 2012, Journal of medicinal chemistry.

Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.

Jeffrey P. Jones, Kanika V. Choughule, Carolyn A. Joswig-Jones, 2015, Biochemical pharmacology.

Purification and Mechanism of Human Aldehyde Oxidase Expressed in Escherichia coli

Jeffrey P. Jones, Joshua F. Alfaro, Carolyn A. Joswig-Jones, 2009, Drug Metabolism and Disposition.

DMD 29520 1 PURIFICATION AND MECHANISM OF HUMAN ALDEHYDE OXIDASE ( AOX 1 ) EXPRESSED IN E . COLI

Jeffrey P. Jones, Joshua F. Alfaro, Carolyn A. Joswig-Jones, 2009 .

Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey

Jeffrey P. Jones, Carolyn A. Joswig-Jones, Armina Abbasi, 2020, Drug Metabolism and Disposition.

Site-Directed Mutagenesis at the MoCo Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey

Jeffrey P. Jones, Carolyn A. Joswig-Jones, Armina Abbasi, 2020 .

In Vitro Oxidative Metabolism of 6-Mercaptopurine in Human Liver: Insights into the Role of the Molybdoflavoenzymes Aldehyde Oxidase, Xanthine Oxidase, and Xanthine Dehydrogenase

Jeffrey P. Jones, C. Barnaba, Kanika V. Choughule, 2014, Drug Metabolism and Disposition.

The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1.

Jeffrey P. Jones, Jeffrey P Jones, Yuzhuo Chu, 2011, Chemico-biological interactions.

The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5‐nitroquinoline

Jeffrey P. Jones, Sara C. Humphreys, Erickson M. Paragas, 2017, Biochemical pharmacology.

The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4.

Jeffrey P. Jones, D. Rock, J. Pearson, 2010, Archives of biochemistry and biophysics.

Time Course of Aldehyde Oxidase and Why It Is Nonlinear

Jeffrey P. Jones, Erickson M. Paragas, John T. Rodgers, 2019, Drug Metabolism and Disposition.

ecoAO: A Simple System for the Study of Human Aldehyde Oxidases Role in Drug Metabolism

Jeffrey P. Jones, Sara C. Humphreys, S. Leimkühler, 2017, ACS omega.

Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometry.

Jeffrey P. Jones, Jeffrey P Jones, John T Barr, 2013, Molecular pharmaceutics.

DMD056374 695..699

Jeffrey P. Jones, S. Strom, E. Schuetz, 2014 .

The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction.

Jeffrey P. Jones, D. Rock, J. Pearson, 2011, Archives of biochemistry and biophysics.

Why Do Most Human Liver Cytosol Preparations Lack Xanthine Oxidase Activity?

Jeffrey P. Jones, S. Strom, E. Schuetz, 2014, Drug Metabolism and Disposition.